| Share Price | 387.75p | Close | 387.75p |
| Change Today | 8.25p | Volume | 90,860 |
| Percent Change | 2.17 % | Day High / Low | 390.00p / 377.25p |
| Update Time | 17:07:32 | Year High / Low | 460.00p / 320.00p |
| Bid | 384.50p | Last Trade Price | 382.82p |
| Offer | 387.75p | Last Trade Amount | 4,131 |
| Open | 380.75p | Last Trade Time | 17:07:29 |
| Period | Price | Change | Percent Change |
|---|---|---|---|
| 1 week | 379.00p | +8.75p | +2.31% |
| 1 month | 364.50p | +23.25p | +6.38% |
| 3 months | 340.00p | +47.75p | +14.04% |
| 6 months | 334.25p | +53.50p | +16.01% |
| 1 year | 403.50p | -15.75p | -3.90% |
| Ex-Marker Code | Ex-Dividend | NMS | 1,000 |
| Ex-Marker Start | 21-Mar-12 | VWAP | 383.82p |
| Ex-Marker End | 20-Apr-12 | Beta | 0.62 |
| Index / Sector | Value | Change | Percent Change |
|---|---|---|---|
| FTSE AIM 100 | 3,168.84 | -3.71 | -0.12% |
| FTSE AIM 50 | 2,922.31 | +1.02 | +0.03% |
| FTSE AIM All-Share | 700.12 | +0.21 | +0.03% |
| Pharmaceuticals & Biotechnology | 9,404.88 | +50.01 | +0.53% |
| Currency | UK Pounds |
| Share Price | 387.75p |
| Change Today | 8.25p |
| % Change | 2.17 % |
| 52 Week High | 460.00p |
| 52 Week Low | 320.00p |
| Volume | 90,860 |
| Shares Issued | 198.17m |
| Market Cap | £768.39m |
| Beta | 0.62 |
| RiskGrade | 107 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 2 |
| Buy | 0 |
| Neutral | 6 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 8 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 21-Mar-12 | 02-Nov-11 |
| Paid | 20-Apr-12 | 25-Nov-11 |
| Amount | 1.69p | 3.80p |
| Time | Volume / Share Price |
| 17:07 | 4,131 @ 382.82p |
| 16:49 | 1,925 @ 383.91p |
| 16:49 | 3,851 @ 383.91p |
| 16:35 | 9,891 @ 387.75p |
| 16:24 | 1,000 @ 385.25p |
| CEO | Jonathan Simon Milner |
| COO | David James Warwick |
You are here: research